Haplotypes of the beta-2 adrenergic receptor associate with high diastolic blood pressure in the Caerphilly prospective study

Journal of Hypertension

Volumn 24, Issue 3, 2006, Pages 471-477

  Binder, Alexander ^a   Garcia, Edwin ^b   Wallace, Chris ^b   Kazeem, Gbenga ^c   Ben Shlomo, Yoav ^d   Yarnell, John ^e   Brown, Philippa ^b   Caulfield, Mark ^b   Skrabal, Falko ^a   Kotanko, Peter ^a,f   Munroe, Patricia ^b  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^f KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

Author keywords

Adrenergic receptor; Genetics; Haplotype; Hypertension

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR;

ADULT; ALLELE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CAUCASIAN; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; DOWN REGULATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOSITY; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 32944454769     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000209983.28735.33     Document Type: Article

References (41)

1. Mein CA, Caulfield MJ, Dobson RJ, Munroe PB. Genetics of essential hypertension. Hum Mol Genet 2004; 13:R169-R175.
2. Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature 2002; 415:206-212.
3. Kirstein SL, Insel PA. Autonomic nervous system pharmacogenomics: a progress report. Pharmacol Rev 2004; 56:31-52.
4. Leineweber K, Brodde OE. Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes. Life Sci 2004; 74:2803-2814.
5. Leineweber K, Buscher R, Bruck H, Brodde OE. Beta-adrenoceptor polymorphisms. Naunyn Schmiedeberg's Arch Pharmacol 2004; 369:1-22.
6. Brodde OE, Leineweber K. Beta2-adrenoceptor gene polymorphisms. Pharmacogenet Genomics 2005; 15:267-275.
7. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994; 33:9414-9419.
8. Drysdale CM, McGraw DW, Stack CB, Stephens JC, Judson RS, Nandabalan K, et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 2000; 97:10483-10488.
9. Gratze G, Fortin J, Labugger R, Binder A, Kotanko P, Timmermann B, et al. Beta-2 adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 1999; 33:1425-1430.
10. Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM, Wood AJ. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 2001; 345:1030-1035.
11. Kotanko P, Binder A, Tasker J, DeFreitas P, Kamdar S, Clark AJ, et al. Essential hypertension in African Caribbeans associates with a variant of the beta2-adrenoceptor. Hypertension 1997; 30:773-776.
12. Hoit BD, Suresh DP, Craft L, Walsh RA, Liggott SB. Beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am Heart J 2000; 139:537-542.
13. Bray MS, Krushkal J, Li L, Ferrell R, Kardia S, Sing CF, et al. Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 2000; 101:2877-2882.
14. Ge D, Huang J, He J, Li B, Duan X, Chen R, Gu D. Beta2-adrenergic receptor gene variations associated with stage-2 hypertension in northern Han Chinese. Ann Hum Genet 2005; 69:36-44.
15. Kato N, Sugiyama T, Morita H, Kurihara H, Sato T, Yamori Y, Yazaki Y. Association analysis of beta(2)-adrenergic receptor polymorphisms with hypertension in Japanese. Hypertension 2001; 37:286-292.
16. Timmermann B, Mo R, Luft FC, Gerdts E, Busjahn A, Omvik P, et al. Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study. Kidney Int 1998; 53:1455-1460.
17. Herrmann SM, Nicaud V, Tiret L, Evans A, Kee F, Ruidavets JB, et al. Polymorphisms of the beta2-adrenoceptor (ADRB2) gene and essential hypertension: the ECTIM and PEGASE studies. J Hypertens 2002; 20:229-235.
18. Herrmann V, Buscher R, Go MM, Ring KM, Hofer JK, Kailasam MT, et al. Beta2-adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in whites and African Americans. Am J Hypertens 2000; 13:1021-1026.
19. Xie HG, Stein CM, Kim RB, Gainer JV, Sofowora G, Dishy V, et al. Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans. Clin Pharmacol Ther 2000; 67:670-675.
20. Galletti F, Iacone R, Ragone E, Russo O, Della Valle E, Siani A, et al. Lack of association between polymorphism in the beta2-adrenergic receptor gene, hypertension, and obesity in the Olivetti heart study. Am J Hypertens 2004; 17:718-720.
21. Candy G, Samani N, Norton G, Woodiwiss A, Radevski I, Wheatley A, et al. Association analysis of beta2 adrenoceptor polymorphisms with hypertension in a Black African population. J Hypertens 2000; 18:167-172.
22. Caerphilly and Speedwell collaborative heart disease studies. The Caerphilly and Speedwell Collaborative Group. J Epidemiol Commun Health 1984; 38:259-262.
23. O'Rourke MF, Kelly RP. Wave reflection in the systemic circulation and its implications in ventricular function. J Hypertens 1993; 11:327-337.
24. Nichols WW, Nicolini FA, Pepine CJ. Determinants of isolated systolic hypertension in the elderly. J Hypertens 1992; 10 (suppl 10):S73-S77.
25. Lander ES, Botstein D. Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 1989; 121:185-199.
26. Darvasi A, Weller JI. On the use of the moments method of estimation to obtain approximate maximum likelihood estimates of linkage between a genetic marker and a quantitative locus. Heredity 1992; 68:43-46.
27. Schork NJ, Nath SK, Fallin D, Chakravarti A. Linkage disequilibrium analysis of biallelic DNA markers, human quantitative trait loci, and threshold-defined case and control subjects. Am J Hum Genet 2000; 67:1208-1218.
28. Tenesa A, Knott SA, Carothers AD, Visscher PM. Power of linkage disequilibrium mapping to detect a quantitative trait locus (QTL) in selected samples of unrelated individuals. Ann Hum Genet 2003; 67:557-566.
29. Carey G, Williamson J. Linkage analysis of quantitative traits: increased power by using selected samples. Am J Hum Genet 1991; 49:786-796.
30. Van Gestel S, Houwing-Duistermaat JJ, Adolfsson R, van Duijn CM, Van Broeckhoven C. Power of selective genotyping in genetic association analyses of quantitative traits. Behav Genet 2000; 30:141-146.
31. Ke X, Cardon LR. Efficient selective screening of haplotype tag SNPs. Bioinformatics 2003; 19:287-288.
32. Howell WM, Jobs M, Gyllensten U, Brookes AJ. Dynamic allele-specific hybridization. A new method for scoring single nucleotide polymorphisms. Nat Biotechnol 1999; 17:87-88.
33. Chapman JM, Cooper JD, Todd JA, Clayton DG. Detecting disease associations due to linkage disequilibrium using haplotype tags: a class of tests and the determinants of statistical power. Hum Hered 2003; 56:18-31.
34. Klein S, Wadden T, Sugerman HJ. AGA technical review on obesity. Gastroenterology 2002; 123:882-932.
35. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290:199-206.
36. Gray DW, Marshall I. Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta. Br J Pharmacol 1992; 107:684-690.
37. Castellano M, Rossi F, Giacche M, Perani C, Rivadossi F, Muiesan ML, et al. Beta(2)-adrenergic receptor gene polymorphism, age, and cardiovascular phenotypes. Hypertension 2003; 41:361-367.
38. Tomaszewski M, Brain NJ, Charchar FJ, Wang WY, Lacka B, Padmanabahn S, et al. Essential hypertension and beta2-adrenergic receptor gene: linkage and association analysis. Hypertension 2002; 40:286-291.
39. Sham P. Statistics in human genetics. London: Hodder Arnold; 1997.
40. Mattu RK, Needham EW, Galton DJ, Frangos E, Clark AJ, Caulfield M. A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation 1995; 91:270-274.
41. Mattu RK, Needham EW, Morgan R, Rees A, Hackshaw AK, Stocks J, et al. DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler Thromb 1994; 14:1090-1097.